- The trend backdrop is active with a 16-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
MMIX
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Multi Medika Internasional Tbk · Healthcare · Pharmaceutical Retailers
Latest close
730.0 IDR
-0.7%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 76.2% above the Trend Line and sits at 76.2% of its 52-week range. The latest completed week returned -0.7%, after a -2.7% four-week move. The latest news-sentiment score is 50/100.
Setup score
67
out of 100
Latest Close
730.0 IDR
7 Aug 2026
1W Return
-0.7%
latest completed week
4W Return
-2.7%
short-term follow-through
12W Return
91.1%
quarterly tape
Trend Breadth
90.4%
47 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- 3 reversal markers appear in the recent smart-money tape.
- The share remains more than 20% below its 52-week high.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.7%
Latest completed week; four-week move -2.7%.
Indicator stack
95/65
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 76.2% above the Trend Line and sits at 76.2% of its 52-week range. The latest completed week returned -0.7%, after a -2.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9512-week average 0.91
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.7% over four weeks, 91.1% over 12 weeks, and 508.3% over one year. The current trend has remained active for 16 consecutive weeks.
Performance by holding period
Active trend streak16 weeks
Active weeks in one year47
Trend breadth90.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.95Latest activity-pressure read.
Pressure change-23.4%Four-week change in activity pressure.
Leadership140.32Latest relative-leadership reading.
RS change-36.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-20.7%Distance below the 52-week high.
13-week volatility22.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2611 weeks finished lower.
Best week+77.7%Week of 5 Jun.
Worst week-13.5%Week of 3 Jul.
Latest week-0.7%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks3
Modest losses7
Sharp losses4
Recent vol22.4%13-week weekly-return volatility.
Base vol13.8%52-week weekly-return volatility.
Up/down split26/23Count of positive and negative weeks in the 52-week window.
Average skew12.3% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank33 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Pharmaceutical Retailers
4-week rank3 / 3
Group average6.1%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD66.7%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape66/100
Trend, activity pressure, participation, and risk combine to a 66/100 tape read.
Indicator analysis85/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.95; 3 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
PT Multi Medika Internasional Tbk Reports Earnings Results for the Half Year Ended June 30, 2026 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 730.0 IDR | -0.7% | 414.2 IDR | 151.6 IDR | 0.95 | 140.32 | 99.7M | On |
| 31 Jul 2026 | 735.0 IDR | 5.0% | 396.9 IDR | 147.6 IDR | 1.13 | 158.99 | 114.5M | On |
| 24 Jul 2026 | 700.0 IDR | -9.1% | 379.6 IDR | 143.6 IDR | 1.05 | 159.38 | 106.1M | On |
| 17 Jul 2026 | 770.0 IDR | 2.7% | 363.3 IDR | 139.8 IDR | 1.24 | 199.21 | 154.2M | On |
| 10 Jul 2026 | 750.0 IDR | 23.0% | 345.3 IDR | 135.6 IDR | 1.24 | 220.22 | 145.6M | On |
| 3 Jul 2026 | 610.0 IDR | -13.5% | 328.2 IDR | 131.6 IDR | 1.31 | 177.80 | 19.5M | On |
| 26 Jun 2026 | 705.0 IDR | -2.1% | 315.4 IDR | 128.5 IDR | 1.71 | 235.31 | 71.0M | On |
| 19 Jun 2026 | 720.0 IDR | -4.0% | 299.3 IDR | 125.0 IDR | 1.63 | 246.51 | 1.8M | On |
| 12 Jun 2026 | 750.0 IDR | 0.0% | 283.2 IDR | 121.2 IDR | 1.60 | 294.30 | 0 | On |
| 5 Jun 2026 | 750.0 IDR | 77.7% | 267.0 IDR | 117.3 IDR | 1.53 | 354.27 | 91.5M | On |
| 29 May 2026 | 422.0 IDR | 16.6% | 250.0 IDR | 113.5 IDR | 1.37 | 153.48 | 16.4M | On |
| 22 May 2026 | 362.0 IDR | -5.2% | 244.4 IDR | 111.9 IDR | 1.27 | 125.45 | 22.3M | On |
| 15 May 2026 | 382.0 IDR | 6.7% | 241.0 IDR | 110.7 IDR | 1.36 | 126.17 | 10.0M | On |
| 8 May 2026 | 358.0 IDR | 19.3% | 235.2 IDR | 109.4 IDR | 1.30 | 112.04 | 25.6M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.